Implantable Mechanical Urinary Sphincter

Information

  • Research Project
  • 6882580
  • ApplicationId
    6882580
  • Core Project Number
    R43DK067699
  • Full Project Number
    1R43DK067699-01A1
  • Serial Number
    67699
  • FOA Number
    PA-01-93
  • Sub Project Id
  • Project Start Date
    4/4/2005 - 20 years ago
  • Project End Date
    9/30/2006 - 18 years ago
  • Program Officer Name
    MULLINS, CHRISTOPHER V.
  • Budget Start Date
    4/4/2005 - 20 years ago
  • Budget End Date
    9/30/2006 - 18 years ago
  • Fiscal Year
    2005
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    4/4/2005 - 20 years ago
Organizations

Implantable Mechanical Urinary Sphincter

DESCRIPTION (provided by applicant): The purpose of this Phase I Proposal is to develop a means to reduce or prevent capsule formation around an implanted mechanical urethral occlusive device. The mechanical design described in this proposal offers significant advantages over existing methods of restoring urinary continence such as bulking agents and hydraulic cuffs. The current configuation of the device demonstrated good occlusion characteristics in acute studies but became inoperable and ineffective within a one to two month period following implantation due to formation of the fibrotic capsule surrounding the implant. Successful reduction of the capsule would permit continued development of this design which has the following advantages: 1) the ability to remove the occlusive pressure surrounding the urethra when voiding, 2) a unitary construction to simplify surgical insertion, 3) a uniform cuircumferiential application of occlusive pressure that avoids the localized pressure points of the hydraulic device and 4) a permanent restoration of urinary control to both male and female patients. These advantages will reduce complications associated with implanting or injecting permanent partial urethral obstructions such as are introduced by slings and bulking agents and reduce tissue erosion problems associated with implanting hydraulic artificial sphincters. A variety of coating materials designed to reduce inflammatory response and tissue proliferation will be applied to the surface of the proposed implants to ascertain their effectiveness in reducing capsule formation around the prosthesis. Devices coated with anti-inflammatory materials, anti-proliferative materials and with both anti-inflammatory and anti-proliferative materials will be implanted and their response compared to uncoated devices. Successful demonstration of a safe and effective capsule reduction coating material will encourage the continuation into a Phase II study with devices prepared for human implantation.

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    R43
  • Administering IC
    DK
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    338377
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    847
  • Ed Inst. Type
  • Funding ICs
    NIDDK:338377\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    GT UROLOGICAL, LLC
  • Organization Department
  • Organization DUNS
    143572159
  • Organization City
    MINNEAPOLIS
  • Organization State
    MN
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    554144504
  • Organization District
    UNITED STATES